SCPC Applauds Inclusion of PBM Reform in Recent Spending Package Approved by U.S. House & Senate
By Staff | Inside Health Policy
The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, released the following statement about the passage of PBM reform:
“SCPC applauds the passage of bipartisan pharmacy benefit manager (PBM) reform legislation by both the U.S. House and Senate, marking a significant step toward greater transparency, accountability, and fairness in the prescription drug marketplace. These reforms address longstanding PBM practices that have created ongoing challenges for seniors’ access to long-term care (LTC) pharmacy services and placed significant strain on the providers delivering that care.
The legislation requires the Centers for Medicare and Medicaid Services (CMS) to define and enforce “reasonable and relevant” Medicare Part D contract terms, providing CMS with clearer enforcement authority to help curb problematic PBM practices. It also promotes transparency by allowing CMS to track payment trends to pharmacies and PBM network participation, giving policymakers better insight into how PBM practices impact access, reimbursement, and sustainability across pharmacy settings, including LTC pharmacies serving our nation’s most frail and medically complex patients.
In addition, the bill prohibits PBM compensation in Medicare Part D from being tied to a drug’s list price. This represents an important step toward lowering prescription drugs costs for consumers and taxpayers alike. While these provisions will not resolve all the challenges facing LTC pharmacies under Medicare Part D, they move the system toward greater stability and accountability and help better protect seniors’ access to essential LTC pharmacy services.
We urge President Trump to swiftly sign these PBM provisions into law so patients and providers can benefit from a fairer, more transparent prescription drug market,” said Alan Rosenbloom President/CEO of SCPC.
# # #
Read the full article on the Inside Health Policy here
Recent Posts
-
LTC pharmacies said this would happen. New data says they were right.
By Donna Shryer // Published July 18, 2026 in McKnight’s Long-Term Care News Long-term care pharmacies predicted a steep reimbursement hit from the Inflation Reduction Act’s Medicare drug pricing changes. Now they say they have the data confirming it. A new analysis of member financial data shows reimbursement for drugs subject to the law’s negotiated […]
-
New Analysis Confirms Drug Pricing Changes Hurt LTC Pharmacies, Reinforces Need for Sustainable Payment Reform
Washington, D.C. (July 16, 2026)— A new analysis of member provided financial data confirms what the Senior Care Pharmacy Coalition (SCPC) has warned: the Inflation Reduction Act’s (IRA) Medicare drug pricing provisions that went into effect in 2026 have significantly reduced reimbursement for long-term care (LTC) pharmacies, threatening their financial sustainability and the benefits of […]
-
LTC Pharmacies Double Down On Call For PBM Contract Negotiation Reform
Lauren Brensel // Inside Health Policy – July 23, 2026 A group representing long-term care pharmacies is reminding policymakers of the negative impacts that result from problematic contract negotiations with pharmacy benefit managers, asking CMS to help alleviate pharmacies’ disputes with the three largest PBMs by embracing a series of reforms. LTC pharmacy services like […]
Stay Connected
Get the latest news and updates on issues impacting the long-term care pharmacy community.